Preventing breast, ovarian cancer in BRCA carriers: Rational of prophylactic surgery and promises of surveillance

被引：66

作者：

Agnantis, NJ

Paraskevaidis, E

Roukos, D ^{[1
]}

机构：

[1] Univ Ioannina, Sch Med, Dept Surg, GR-45110 Ioannina, Greece

[2] Univ Ioannina, Sch Med, Dept Pathol, GR-45110 Ioannina, Greece

[3] Univ Ioannina, Sch Med, Dept Gynecol & Obstet, GR-45110 Ioannina, Greece

来源：

ANNALS OF SURGICAL ONCOLOGY | 2004年 / 11卷 / 12期

关键词：

D O I：

10.1245/ASO.2004.09.910

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

引用

页码：1030 / 1034

页数：5

共 42 条

[21] Potential for bias in studies on efficacy of prophylactic surgery for BRCA1 and BRCA2 mutation [J].

Klaren, HM ;

van't Veer, LJ ;

van Leeuwen, FE ;

Rookus, MA .

JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2003, 95 (13) :941-947

[22] Efficacy of MRI and mammography for breast-cancer screening in women with a familial or genetic predisposition [J].

Kriege, M ;

Brekelmans, CTM ;

Boetes, C ;

Besnard, PE ;

Zonderland, HM ;

Obdeijn, IM ;

Manoliu, RA ;

Kok, T ;

Peterse, H ;

Tilanus-Linthorst, MMA ;

Muller, SH ;

Meijer, S ;

Oosterwijk, JC ;

Beex, LVAM ;

Tollenaar, RAEM ;

de Koning, HJ ;

Rutgers, EJT ;

Klijn, JGM .

NEW ENGLAND JOURNAL OF MEDICINE, 2004, 351 (05) :427-437

[23] Breast cancer after prophylactic bilateral mastectomy in women with a BRCA1 or BRCA2 mutation. [J].

Meijers-Heijboer, H ;

van Geel, B ;

van Putten, WLJ ;

Henzen-Logmans, SC ;

Seynaeve, C ;

Menke-Pluymers, MBE ;

Bartels, CCM ;

Verhoog, LC ;

van den Ouweland, AMW ;

Niermeijer, MF ;

Brekelmans, CTM ;

Klijn, JGM .

NEW ENGLAND JOURNAL OF MEDICINE, 2001, 345 (03) :159-164

[24] Contralateral breast cancer in BRCA1 and BRCA2 mutation carriers [J].

Metcalfe, K ;

Lynch, HT ;

Chadirian, P ;

Tung, N ;

Olivotto, V ;

Warner, E ;

Olopade, OI ;

Eisen, A ;

Weber, B ;

McLennan, J ;

Sun, P ;

Foulkes, WD ;

Narod, SA .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (12) :2328-2335

[25] Psychosocial functioning in women who have undergone bilateral prophylactic mastectomy [J].

Metcalfe, KA ;

Esplen, MJ ;

Goel, V ;

Narod, SA .

PSYCHO-ONCOLOGY, 2004, 13 (01) :14-25

[26] Modifiers of risk of hereditary breast and ovarian cancer [J].

Narod, SA .

NATURE REVIEWS CANCER, 2002, 2 (02) :113-+

[27] Breast cancer genetics: What we know and what we need [J].

Nathanson, KN ;

Wooster, R ;

Weber, BL .

NATURE MEDICINE, 2001, 7 (05) :552-556

[28] Breast cancer risk after bilateral prophylactic oophorectomy in BRCA1 mutation carriers [J].

Rebbeck, TR ;

Levin, AM ;

Eisen, A ;

Snyder, C ;

Watson, P ;

Cannon-Albright, L ;

Isaacs, C ;

Olopade, O ;

Garber, JE ;

Godwin, AK ;

Daly, MB ;

Narod, SA ;

Neuhausen, SL ;

Lynch, HT ;

Weber, BL .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 1999, 91 (17) :1475-1479

[29] Prophylactic oophorectomy in carriers of BRCA1 or BRCA2 mutations [J].

Rebbeck, TR ;

Lynch, HT ;

Neuhausen, SL ;

Narod, SA ;

van't Veer, L ;

Garber, JE ;

Evans, G ;

Isaacs, C ;

Daly, MB ;

Matloff, E ;

Olopade, OI ;

Weber, BL .

NEW ENGLAND JOURNAL OF MEDICINE, 2002, 346 (21) :1616-1622

[30] Bilateral prophylactic mastectomy reduces breast cancer risk in BRCA1 and BRCA2 mutation carriers:: The PROSE study group [J].

Rebbeck, TR ;

Friebel, T ;

Lynch, HT ;

Neuhausen, SL ;

van't Veer, L ;

Garber, JE ;

Evans, GR ;

Narod, SA ;

Isaacs, C ;

Matloff, E ;

Daly, MB ;

Olopade, OI ;

Weber, BL .

JOURNAL OF CLINICAL ONCOLOGY, 2004, 22 (06) :1055-1062

← 1 2 3 4 5 →